A long-awaited meta-analysis has been recently published (September 17, 2020) and correlates increased Omega-3 oral intakes to positive cardiovascular benefits. A total of 40 studies combining 135,267 participants, were included in the analysis.
The article, which was published in Mayo Clinic Proceedings, found that EPA/DHA supplementation was associated with the following major reductions in cardiovascular outcomes: 35% reduced risk of fatal myocardial infarction (MI), 13% reduced risk of MI, 10% reduced risk of coronary heart disease (CHD) events, 9% reduced risk of CHD mortality and 5% reduction of cardiovascular disease (CVD) event.
More importantly, there was a protective effect when increasing the dosage. An additional one gram per day of EPA + DHA resulted in an additional, statistically significant, 9% reduction in the risk of MI and 5.8% reduction in the risk of CVD events.
Watch here an explanatory video from Dr. Carl (Chip) Lavie, a Cardiologist at the Ochsner Heart and Vascular Clinic in New Orleans, LA, co-author of this study.
Click here to download the full-published meta-analysis.
Related Ingredient to this article: Golden Omega Fish Oil Concentrates